Form 8-K - Current report:
SEC Accession No. 0001193125-24-261743
Filing Date
2024-11-19
Accepted
2024-11-19 16:19:31
Documents
15
Period of Report
2024-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d653097d8k.htm   iXBRL 8-K 34523
2 EX-10.1 d653097dex101.htm EX-10.1 518359
3 EX-99.1 d653097dex991.htm EX-99.1 229533
  Complete submission text file 0001193125-24-261743.txt   1049859

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dlb-20241114.xsd EX-101.SCH 2842
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dlb-20241114_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dlb-20241114_pre.xml EX-101.PRE 10808
17 EXTRACTED XBRL INSTANCE DOCUMENT d653097d8k_htm.xml XML 3510
Mailing Address 1275 MARKET STREET SAN FRANCISCO CA 94103
Business Address 1275 MARKET STREET SAN FRANCISCO CA 94103 415 558 0200
Dolby Laboratories, Inc. (Filer) CIK: 0001308547 (see all company filings)

EIN.: 900199783 | State of Incorp.: DE | Fiscal Year End: 0927
Type: 8-K | Act: 34 | File No.: 001-32431 | Film No.: 241476398
SIC: 6794 Patent Owners & Lessors
(CF Office: 05 Real Estate & Construction)